Assessment of Predictive Biomarkers of the Response to Pazopanib Based on an Integrative Analysis of High-grade Soft-tissue Sarcomas: Analysis of a Tumor Sample from a Responder and Patients with Other Soft-tissue Sarcomas

BACKGROUND: Soft-tissue sarcomas are a rare group of malignant tumors that usually are treated with surgical excision and radiation therapy, but recently, pazopanib, an oral tyrosine kinase inhibitor, has been used in patients with metastases who do not respond to standard chemotherapy regimens. Bas...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Orthop Relat Res
Autori principali: Suehara, Yoshiyuki, Kohsaka, Shinji, Yamaguchi, Shigeo, Hayashi, Takuo, Kurihara, Taisei, Sano, Kei, Sasa, Keita, Akaike, Keisuke, Ueno, Toshihide, Kojima, Shinya, Ikegami, Masachika, Mizuno, Sho, Okubo, Taketo, Kim, Youngji, Kaneko, Kazuo, Saito, Tsuyoshi, Kato, Shunsuke, Mano, Hiroyuki
Natura: Artigo
Lingua:Inglês
Pubblicazione: Wolters Kluwer 2020
Soggetti:
Selected Proceedings of the 2019 International Society of Limb Salvage Annual Meeting (Guest Editor: John H. Healey, Md)
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7594915/
https://ncbi.nlm.nih.gov/pubmed/32567826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CORR.0000000000001322
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi